The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
Related posts:
Vaccination sprint threatens to leave behind minority communities
AstraZeneca releases revised vaccine data that show dip in efficacy
Vaccine demand jumps in states pummeled by Delta variant
Pandemic Olympics come to an end in Tokyo
Pentagon will seek to mandate Covid vaccine for 1.4 million troops
Divided Supreme Court considers who can defend abortion restrictions
Congressional resistance puts future Covid funds in jeopardy
Health data breaches swell in 2021 amid hacking surge, POLITICO analysis finds
Abortion doctors’ post-Roe dilemma: Move, stay or straddle state lines
Georgia lower court blocks state’s six-week abortion ban
Biden’s HIPAA expansion for abortion draws criticism, lawsuit threats
Five takeaways from the Milken Institute Future of Health Summit
